These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 25042850

  • 1. Diabetic macular oedema quantified with spectral-domain optical coherence tomography--evaluation of boundary line artefacts and the effect on retinal thickness.
    Hodzic-Hadzibegovic D, Sander BA, Lund-Andersen H.
    Acta Ophthalmol; 2015 Feb; 93(1):74-82. PubMed ID: 25042850
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
    Santos AR, Gomes SC, Figueira J, Nunes S, Lobo CL, Cunha-Vaz JG.
    Ophthalmologica; 2014 Feb; 231(1):16-22. PubMed ID: 24280908
    [Abstract] [Full Text] [Related]

  • 6. Diameter of retinal vessels in patients with diabetic macular edema is not altered by intravitreal ranibizumab (lucentis).
    Terai N, Haustein M, Siegel A, Stodtmeister R, Pillunat LE, Sandner D.
    Retina; 2014 Jul; 34(7):1466-72. PubMed ID: 24457978
    [Abstract] [Full Text] [Related]

  • 7. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
    Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS, Larsen M.
    Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. VISUAL AND MORPHOLOGIC OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR DIABETIC MACULAR EDEMA BASED ON OPTICAL COHERENCE TOMOGRAPHY PATTERNS.
    Seo KH, Yu SY, Kim M, Kwak HW.
    Retina; 2016 Mar; 36(3):588-95. PubMed ID: 26398695
    [Abstract] [Full Text] [Related]

  • 11. The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema.
    Matsuda S, Tam T, Singh RP, Kaiser PK, Petkovsek D, Carneiro G, Zanella MT, Ehlers JP.
    J Diabetes Complications; 2014 Mar; 28(2):166-70. PubMed ID: 24374138
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis--potential role as biomarker of response to ranibizumab treatment.
    Leicht SF, Kernt M, Neubauer A, Wolf A, Oliveira CM, Ulbig M, Haritoglou C.
    Ophthalmologica; 2014 Mar; 231(4):198-203. PubMed ID: 24662930
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spectral domain optical coherence tomography predictors of visual outcome in diabetic cystoid macular edema after bevacizumab injection.
    Al Faran A, Mousa A, Al Shamsi H, Al Gaeed A, Ghazi NG.
    Retina; 2014 Jun; 34(6):1208-15. PubMed ID: 24368308
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.
    Chae JB, Joe SG, Yang SJ, Lee JY, Sung KR, Kim JY, Kim JG, Yoon YH.
    Retina; 2014 Jan; 34(1):149-56. PubMed ID: 23807186
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.